RALYANT

human pharmaceuticals for the treatment of auto-immune, immunological, inflammation and inflammatory diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, central nervous system diseases and disorders, infectious-related diseases and disorders, anti-viral diseases and disorders, oncological related diseases and disorders, neurological related diseases and disorders, pain, dermatological related diseases and disorders, reproductive and urological diseases and disorders, and psychiatric related diseases and disorders